Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Cheung
    Cheung
  8. Voss
    Voss
  9. O'Reilly
    O'Reilly
  10. Robson
    Robson

Groups

  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)
  7. Epidemiology and Biostatistics (151)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (121)
  10. Surgery (118)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Roberta Zappasodi (24)

More People

Years
  1. 2025 (28)
  2. 2024 (63)
  3. 2023 (45)
  4. 2022 (123)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (404)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (46)
  5. Journal of Hematology & Oncology (42)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
    Guidelines

    Rini, B. I.; Battle, D.; Figlin, R. A.; George, D. J.; Hammers, H.; Hutson, T.; Jonasch, E.; Joseph, R. W.; McDermott, D. F.; Motzer, R. J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
    Journal Article

    Kazachenka, A.; Young, G. R.; Attig, J.; Kordella, C.; Lamprianidou, E.; Zoulia, E.; Vrachiolias, G.; Papoutselis, M.; Bernard, E.; Papaemmanuil, E.; more...
    Genome Medicine (2019)

    Fulltext@MSK | Save
  • Metachronous renal cell carcinoma with metastasis to the urinary bladder, and distant organs, 28 years after radical nephrectomy: A case report
    Journal Article

    Babar, M.; Hamdani, S.; Liu, C.; Vedula, J.; Schnapp, D. S.
    BMC Urology (2019)

    Fulltext@MSK | Save
  • Interpretable deep neural network for cancer survival analysis by integrating genomic and clinical data
    Journal Article

    Hao, J.; Kim, Y.; Mallavarapu, T.; Oh, J. H.; Kang, M.
    BMC Medical Genomics (2019)

    Fulltext@MSK | Save
  • Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: Current knowledge and future research directions
    Review

    Hilmi, M.; Neuzillet, C.; Calderaro, J.; Lafdil, F.; Pawlotsky, J. M.; Rousseau, B.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
    Journal Article

    Shah, N. J.; Al-Shbool, G.; Blackburn, M.; Cook, M.; Belouali, A.; Liu, S. V.; Madhavan, S.; He, A. R.; Atkins, M. B.; Gibney, G. T.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI
    Journal Article

    Avendano, D.; Marino, M. A.; Leithner, D.; Thakur, S.; Bernard-Davila, B.; Martinez, D. F.; Helbich, T. H.; Morris, E. A.; Jochelson, M. S.; Baltzer, P. A. T.; more...
    Breast Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase 1 study of NY-ESO-1 vaccine + ipilimumab (ipi) in patients with unresectable or metastatic melanoma
    Meeting Abstract

    Slingluff, C.; Zarour, H.; Postow, M.; Friedlander, P.; Devoe, C.; Mauldin, I.; Smith, K.; Macri, M.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC): The phase 3 KEYNOTE-689 study
    Meeting Abstract

    Uppaluri, R.; Lee, N.; Westra, W.; Cohen, E.; Haddad, R.; Temam, S.; Le Tourneau, C.; Chernock, R.; Safina, S.; Klochikhin, A.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • First-in-class small molecule CA-170 targeting VISTA: A report on efficacy outcomes from a cohort of 12 malignant pleural mesothelioma (MPM) patients in study CA-170-101
    Meeting Abstract

    Zauderer, M.; Brody, J.; Marron, T.; Pacey, S.; Martell, R.; Wang, H.; Spicer, J.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save